Oh HS, Oh SK, Lee JS et al
Every 8-12 weeks during active weight loss is a reasonable approach
This is a crucial point: injecting into the stomach does not burn fat in the stomach specifically, nor does injecting into the thigh target leg fat
Although multiple therapeutic strategies targeting different pathological processes of MASH, including lipid accumulation, inflammation, and fibrosis, are under clinical trials, only two pharmacologic treatment, Resmetirom, a thyroid hormone receptor- agonist, and Semaglutide, a GLP-1 receptor agonist, have been approved by the FDA for clinical use 4,5,6
The sunflower-derived phospholipids (non-soy product for those with soy sensitivities) are GMO-free and 100% vegan
Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause